Processing 00000000.tx.1: Glucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro Christian Behl, Frank Lezoualch1, Thorsten Trapp, Martina Widmann, Thomas Skutella2 and Florian Holsboer Max Planck Institute of Psychiatry, Clinical Institute, Munich, Germany Address all correspondence and requests for reprints to: Christian Behl Ph.D., Clinical Institute, Department of Neuroendocrinology, Max Planck Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. 

Phrase: "Glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "Enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro Christian Behl,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0007587:Cell Death [Cell Function]
   751   C2754100:neuron cell death [Cell Function]
           neuron death
   736   C0007634:Cell [Cell]
   736   C0011065:Death [Organism Function]
   736   C1269647:Cell [Cell]
   736   C1306577:Death, NOS [Finding]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]

Phrase: "Frank Lezoualch1,"

Phrase: "Thorsten Trapp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0913340:trapp [Amino Acid, Peptide, or Protein]
   861   C1166859:trapp [Cell Component]

Phrase: "Martina Widmann,"

Phrase: "Thomas Skutella2"

Phrase: "and"

Phrase: "Florian Holsboer Max Planck Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "Clinical Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Munich,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Christian Behl Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1512022:Ph.D. [Intellectual Product]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: "Clinical Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Department of Neuroendocrinology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Max Planck Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Kraepelinstrasse 10,"

Phrase: "80804 Munich,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.2: E-mail: chris{at}mpipsykl.mpg.de  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  In patients with Alzheimers disease, hippocampal cells are among the first neuronal cells of the brain to degenerate. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "chris{at}mpipsykl.mpg.de  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]

Phrase: "with Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "hippocampal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are among the first neuronal cells of the brain to"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   757   C0596208:brain cells [Cell]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0007634:Cells [Cell]
   739   C0205435:First [Quantitative Concept]
   739   C0521390:Neuronal [Immunologic Factor]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1279901:First [Qualitative Concept]
   739   C1551058:Are [Quantitative Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "degenerate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:degenerate [Pathologic Function]
  1000   C1880269:Degenerate [Functional Concept]
Processing 00000000.tx.3: Both rat primary hippocampal neurons and cells of the clonal mouse hippocampal cell line HT22 express endogenous functional glucocorticoid receptors (GRs), as shown by transient transfection of cells with a luciferase reporter plasmid containing GR-responsive elements. 

Phrase: "Both rat primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "cells of the clonal mouse hippocampal cell line HT22"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1513528:Mouse Cell Line [Cell]
   762   C0007600:cells line [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   726   C0009013:Clone Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "endogenous functional glucocorticoid receptors (GRs),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   827 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   827 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0017710:Glucocorticoid [Hormone,Steroid]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as"

Phrase: "shown by transient transfection of cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   753   C0040704:Transient [Population Group]
   753   C0205374:Transient [Temporal Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1547282:Show [Intellectual Product]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with a luciferase reporter plasmid containing GR-responsive elements."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0013879:Elements [Element, Ion, or Isotope]
   795   C0205342:Responsive [Functional Concept]
   762 E C1705248:Element [Conceptual Entity]
   724 E C2371924:Responsivity [Mental Process]
Processing 00000000.tx.4: The influence of activated GRs on oxidative stress-induced neuronal cell death in vitro was investigated employing these hippocampal model systems. 

Phrase: "The influence of activated GRs"

Phrase: "on oxidative stress-induced neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C2754100:neuronal cell death [Cell Function]
           neuron death
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "these hippocampal model systems."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0026339:Model System [Intellectual Product,Research Device]
   884   C3161035:Model System [Intellectual Product]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.5: Two oxidative stressors were investigated, the free radical-inducing Alzheimers disease-associated amyloid -protein, which is toxic to hippocampal neurons, and the excitatory amino acid glutamate, which induces oxidative cell death in HT22 cells via an increase in intracellular peroxides. 

Phrase: "Two oxidative stressors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597530:stressors [Idea or Concept]

Phrase: "were"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "the free radical-inducing Alzheimers disease-associated amyloid -protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "toxic to hippocampal neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "and"

Phrase: "the excitatory amino acid glutamate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   812   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0243046:Excitatory Amino Acid [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative cell death in HT22 cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
           cells death
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "via an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in intracellular peroxides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031180:Peroxides [Inorganic Chemical]
Processing 00000000.tx.6: Cellular viability was assessed with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide test and trypan exclusion staining, followed by microscopical cell counting. 

Phrase: "Cellular viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443348:viability [Qualitative Concept]

Phrase: "was"

Phrase: "assessed with the 3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516048:Assessed [Activity]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl-tetrazolium bromide test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]

Phrase: "and"

Phrase: "trypan exclusion staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "followed by microscopical cell counting."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0007584:cell counting [Laboratory Procedure]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   731   C1441646:Microscopic count [Laboratory Procedure]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.7: Glucocorticoids strongly increased the vulnerability of the hippocampal cells to amyloid -protein and glutamate. 

Phrase: "Glucocorticoids strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the vulnerability of the hippocampal cells"

Phrase: "to amyloid -protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: This increase could be blocked by the specific GR antagonist RU486. 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "blocked by the specific GR antagonist RU486."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0028778:Blocked [Pathologic Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0231491:Antagonist [Organ or Tissue Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0701303:RU486 [Pharmacologic Substance,Steroid]
   748   C1552740:specific [Intellectual Product]
   748   C1552950:[gr] [Quantitative Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.9: Our data suggest that changes in hippocampal GR homeostasis and regulation may render hippocampal neurons more vulnerable to oxidative stress-induced neuronal degeneration.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that changes in hippocampal GR homeostasis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "render"

Phrase: "hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "more vulnerable to oxidative stress-induced neuronal degeneration."
Processing 00000000.tx.10: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  THE HIPPOCAMPUS is a primary target for neuronal degeneration in the brains of patients with Alzheimers disease (AD). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "THE HIPPOCAMPUS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a primary target for neuronal degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimers disease (AD)."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: Because hippocampal cells express glucocorticoid receptors (GRs), they are the principal target sites for glucocorticoids, the adrenocortical hormones secreted during stress (1). 

Phrase: "Because"

Phrase: "hippocampal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "glucocorticoid receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(GRs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: ","

Phrase: "they"

Phrase: "are"

Phrase: "the principal target sites for glucocorticoids,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "the adrenocortical hormones"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019932:Hormones [Hormone]
   861   C2986474:Adrenocortical [Qualitative Concept]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "secreted during stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0038435:Stress [Finding]
   790   C1327616:Secreted [Cell Function]
   718 E C0231297:Stressful [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: The hippocampus is very sensitive to many types of neurological insults. 

Phrase: "The hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "very sensitive to many types of neurological insults."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332324:Sensitive to [Functional Concept]
           Sensitive
   744   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.13: Under certain conditions glucocorticoids exacerbate this sensitivity during pathological insults such as seizures, antimetabolite exposure, hypoxia-ischemia, and exposure to various neurotoxins (2, 3, 4). 

Phrase: "Under certain conditions glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "exacerbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "this sensitivity during pathological insults"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "such as seizures,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0036572:Seizures [Sign or Symptom]
   966 E C1959629:Seizure [Finding]

Phrase: "antimetabolite exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "hypoxia-ischemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "and"

Phrase: "exposure to various neurotoxins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.14: It has been reported that an altered response of the hypothalamic-pituitary-adrenal (HPA) system occurs in patients with AD and that these alterations may increase glucocorticoid levels (5). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "an altered response of the hypothalamic-pituitary-adrenal (HPA) system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "occurs in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "with AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "these alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "glucocorticoid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.15: Amyloid -protein (A) is a 40- to 43-amino acid peptide that is associated with plaques in the brains of patients with AD and is cytotoxic to neurons (6, 7, 8, 9, 10). 

Phrase: "Amyloid -protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "is"

Phrase: "a 40-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "to 43-amino acid peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "is"

Phrase: "associated with plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0333463:plaques [Acquired Abnormality]
   756 E C0011389:Plaque [Disease or Syndrome]
   756 E C0332461:Plaque [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "cytotoxic to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   790   C1511636:cytotoxic [Functional Concept]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.16: A-induced cytotoxicity has been shown to be caused by the intracellular accumulation of H2O2, ultimately leading to peroxidation of membrane lipids and cell death (6). 

Phrase: "A-induced cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused by the intracellular accumulation of H2O2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0175996:intracellular [Cell Component]
   748   C0178719:Intracellular [Spatial Concept]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "ultimately"

Phrase: "leading to peroxidation of membrane lipids"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0025249:Membrane Lipids [Cell Component,Lipid]
   767   C0023775:Lipid Peroxidation [Molecular Function]
   753   C0023779:Lipids [Lipid]
   753   C0025255:Membrane [Tissue]
   753   C0178796:peroxidation [Phenomenon or Process]
   753   C0332152:Leading [Temporal Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1522538:Leading [Functional Concept]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.17: In addition to its direct toxic effect, A increases the vulnerability of rodent and human neurons to excitotoxins (8, 9). 

Phrase: "In addition to its direct toxic effect,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   827   C1280500:Effect [Qualitative Concept]
   827   C1407029:Toxic [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "A"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the vulnerability of rodent"

Phrase: "and"

Phrase: "human neurons to excitotoxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.18: Excitatory amino acids, such as glutamate, may be directly toxic to cultured neuronal cells via two different processes. 

Phrase: "Excitatory amino acids,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0243046:Excitatory Amino Acids [Amino Acid, Peptide, or Protein]
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "such as glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "directly toxic to cultured neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]

Phrase: "via two different processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.19: The classical pathway is mediated by specific glutamate receptors that can be blocked by specific glutamate receptor antagonists (11). 

Phrase: "The classical pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439858:Classical [Qualitative Concept]
   861   C0443177:Classical [Functional Concept]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "mediated by specific glutamate receptors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0061465:Receptors, Glutamate [Amino Acid, Peptide, or Protein,Receptor]
   760   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1552740:specific [Intellectual Product]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "blocked by specific glutamate receptor antagonists"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   833   C0242910:Glutamate Receptor Antagonists [Pharmacologic Substance]
           Glutamate Antagonists
   790   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0028778:Blocked [Pathologic Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243076:antagonists [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1552740:specific [Intellectual Product]
   753   C2983591:BLOCKED [Research Activity]
   719 E C0231491:Antagonist [Organ or Tissue Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.20: Excitatory amino acid neurotoxicity may also be caused by the induction of an imbalance in antioxidant enzyme systems and a reduction in intracellular glutathione levels that ultimately lead to the intracellular accumulation of peroxides and cell death. 

Phrase: "Excitatory amino acid neurotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0235032:Neurotoxicity [Injury or Poisoning]
   756   C0243046:Excitatory Amino Acid [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "caused by the induction of an imbalance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1397014:Imbalance [Sign or Symptom]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "in antioxidant enzyme systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "a reduction in intracellular glutathione levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "that ultimately"

Phrase: "lead to the intracellular accumulation of peroxides"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0031180:Peroxides [Inorganic Chemical]
   748   C0175996:intracellular [Cell Component]
   748   C0178719:Intracellular [Spatial Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.21: The drop in glutathione levels has been shown to arise from the competition by glutamate for a glutamate/cystine antiporter, leading to an imbalance in the homeostasis of cystine, the precursor of glutathione formation (12). 

Phrase: "The drop in glutathione levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1321095:Drop [Quantitative Concept]
   760   C1705648:Drop [Activity]
   760   C2347093:Drop [Quantitative Concept]
   760   C2348338:Drop [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "arise from the competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679932:competition [Social Behavior]

Phrase: "by glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for a glutamate/cystine antiporter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0052088:antiporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "leading to an imbalance"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C1397014:Imbalance [Sign or Symptom]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019868:Homeostasis [Biologic Function]

Phrase: "of cystine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010682:Cystine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0546634:CYSTINE [Laboratory Procedure]

Phrase: "the precursor of glutathione formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.22: This second pathway can be blocked by the addition of antioxidants, which demonstrates the involvement of free radicals and oxidative stress (12, 13). 

Phrase: "This second pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0682673:second pathway [Body Part, Organ, or Organ Component]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by the addition of antioxidants,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0003402:Antioxidants [Pharmacologic Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C1883712:Addition [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "which"

Phrase: "demonstrates"

Phrase: "the involvement of free radicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.23: In addition, several reports suggest that independently of the pathway, glutamate can induce the generation of several reactive oxygen species in neurons, such as the superoxide anion (14) and hydrogen peroxide (15). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that independently of the pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the generation of several reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "in neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "such as the superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.24: Glutamate has been implicated in various neurodegenerative diseases, such as AD, Huntingtons disease, and Parkinsons disease (16). 

Phrase: "Glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in various neurodegenerative diseases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "such as AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Huntingtons disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.25: HT22 cells are sensitive to glutamate (13). 

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "sensitive to glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.26: Glutamate receptor antagonists do not protect HT22 cells from glutamate toxicity. 

Phrase: "Glutamate receptor antagonists"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0242910:Glutamate Receptor Antagonists [Pharmacologic Substance]
           Glutamate Antagonists
   827   C0243076:antagonists [Chemical Viewed Functionally]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   734   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "protect"

Phrase: "HT22 cells from glutamate toxicity."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.27: This observation together with the finding that antioxidants, such as vitamin E, and high extracellular cystine levels protect these hippocampal cells from glutamate toxicity indicate that glutamate-induced cell death occurs via an oxidative pathway (13). 

Phrase: "This observation together with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]

Phrase: "that antioxidants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "such as vitamin E,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "high extracellular cystine levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "protect"

Phrase: "these hippocampal cells from glutamate toxicity"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "indicate"

Phrase: "that glutamate-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "occurs via an oxidative pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0311404:Oxidative [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.28: Therefore, the toxicities of A and glutamate were used as paradigms of oxidative stress-induced cell death in hippocampal neurons. 

Phrase: "Therefore,"

Phrase: "the toxicities of A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0600688:toxicities [Injury or Poisoning]
   737 E C0040539:toxicity [Qualitative Concept]

Phrase: "and"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "used as paradigms of oxidative stress-induced cell death"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0007587:Cell Death [Cell Function]
   764   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   745   C1524063:Use of [Functional Concept]
   742   C0007634:Cell [Cell]
   742   C0011065:Death [Organism Function]
   742   C0038435:Stress [Finding]
   742   C0205263:Induced [Functional Concept]
   742   C0311404:Oxidative [Functional Concept]
   742   C0681797:paradigms [Research Activity]
   742   C1269647:Cell [Cell]
   742   C1273517:used [Finding]
   742   C1306577:Death, NOS [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.29: Data are accumulating that the activities of different steroids can have an impact on neuronal function and the sensitivity of neurons to different toxic insults (4, 17, 18, 19, 20). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "accumulating"

Phrase: "that"

Phrase: "the activities of different steroids"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "have"

Phrase: "an impact on neuronal function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "the sensitivity of neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to different toxic insults"

Phrase: "(4,"

Phrase: "17,"

Phrase: "18,"

Phrase: "19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.30: Recently, we showed that the sex hormone 17-estradiol is an effective neuroprotector against oxidative stress-induced cell death (21). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the sex hormone 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   756 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   756 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "an effective neuroprotector against oxidative stress-induced cell death"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.31: To investigate whether glucocorticoids can increase the sensitivity of hippocampal neurons to A and glutamate, we studied the influence of glucocorticoids on the cell death caused by these neurotoxins using the clonal mouse hippocampal cell line HT22 and rat primary hippocampal neurons.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the sensitivity of hippocampal neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to A"

Phrase: "and"

Phrase: "glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the influence of glucocorticoids"

Phrase: "on the cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "caused by these neurotoxins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027934:Neurotoxins [Hazardous or Poisonous Substance]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the clonal mouse hippocampal cell line HT22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   700   C1513528:Mouse Cell Line [Cell]

Phrase: "and"

Phrase: "rat primary hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.32: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Cell culture and chemicals The cell line HT22 is a subclone of the HT4 hippocampal cell line (22). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "The cell line HT22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0007600:Cell Line [Cell]

Phrase: "is"

Phrase: "a subclone of the HT4 hippocampal cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1883178:Subclone [Cell]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.33: HT22 cells were a gift from Dr. 

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "a gift from Dr."
Processing 00000000.tx.34: David Schubert (The Salk Institute, San Diego, CA). 

Phrase: "David Schubert"

Phrase: "("

Phrase: "The Salk Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.35: They were cultured in DMEM supplemented with 10% FCS under standard culture conditions. 

Phrase: "They"

Phrase: "were"

Phrase: "cultured in DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10% FCS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "under standard culture conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.36: Rat primary cultures were prepared from embryonic day 19 (E19) hippocampi, as previously described (10). 

Phrase: "Rat primary cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0010453:Cultures [Idea or Concept]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from embryonic day 19 (E19) hippocampi,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   719   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.37: Primary cells were cultured on poly-L-lysine-coated dishes in 50% DMEM (4500 mg/liter glucose)-50% Hams F-12 medium that contained N2 supplements. 

Phrase: "Primary cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007634:Cells [Cell]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured on poly-L-lysine-coated dishes"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   748   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0747726:POLY [Conceptual Entity]
   748   C1522408:Coated [Qualitative Concept]
   714   C0010453:Culture [Idea or Concept]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714 E C0453946:Coat [Manufactured Object]
   714   C2242979:Culture [Laboratory Procedure]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "in 50% DMEM"

Phrase: "(4500 mg/liter glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")-"

Phrase: "50% Hams F-12 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0009458:Medium [Intellectual Product]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]

Phrase: "that contained N2 supplements."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0242295:Supplement [Food]
   793   C1947943:Supplement [Intellectual Product]
   793   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.38: Using these minimal culture conditions, more than 95% of the cells were neuronal, as confirmed by staining with neuron-specific enolase and by the absence of glial fibrillary acidic protein-positive cells. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these minimal culture conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "more than 95% of the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C0205172:More [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "neuronal,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "as"

Phrase: "confirmed by staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0487602:Staining [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   790   C1704680:Staining [Finding]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "with neuron-specific enolase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
  1000   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
   827   C0027882:Neuron [Cell]
   827   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
   755 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and by the absence of glial fibrillary acidic protein-positive cells."
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   797   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1325793:glial fibrillary acidic protein [Cell Component]
   797   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   756   C0439178:% positive cells [Quantitative Concept]
           % Positive
   754   C0027836:Glial Cells [Cell]
           Glial
   738   C0001128:Acidic [Chemical]
   738   C0007634:Cells [Cell]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332197:absence [Quantitative Concept]
   738   C1446409:Positive [Qualitative Concept]
   738   C1514241:Positive [Finding]
   738   C1515981:And [Idea or Concept]
   738   C1689985:Absence [Anatomical Abnormality]
   738   C2825490:Positive [Qualitative Concept]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.39: A2535 was obtained from Saxon (Hanover, Germany). 

Phrase: "A2535"

Phrase: "was"

Phrase: "obtained from Saxon"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Hanover,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.40: All media, sera, and medium supplements were purchased from Life Technologies (Eggenstein, Germany). 

Phrase: "All media,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "sera,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0229671:Sera [Body Substance]
  1000   C1151254:SerA [Molecular Function]
   966 E C1546774:Serum [Intellectual Product]
   966 E C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "medium supplements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "were"

Phrase: "purchased from Life Technologies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C0869011:purchased [Activity]

Phrase: "(Eggenstein,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.41: RU486 was a gift from Dr. 

Phrase: "RU486"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0701303:RU486 [Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "a gift from Dr."
Processing 00000000.tx.42: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.43: Renoir (Baulieu Laboratory, Paris, France). 

Phrase: "Renoir"

Phrase: "(Baulieu Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.44: Dexamethasone, corticosterone, and all other reagents were purchased from Sigma Chemical Co. 

Phrase: "Dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "corticosterone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "all other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Sigma Chemical Co."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0220806:Chemical [Chemical]
   760   C0869011:purchased [Activity]
   760   C1719918:Sigma [Intellectual Product]
   760   C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.45: (Germany). 

Phrase: "(Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.46: Transfections and assays for luciferase and -galactosidase activities HT22 cells were grown in DMEM supplemented with 10% FCS. 

Phrase: "Transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "assays for luciferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "and -"

Phrase: "galactosidase activities HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM"

Phrase: "supplemented with 10% FCS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.47: Transient transfections were performed using an electroporation system (Biotechnologies and Experimental Research, San Diego, CA) after determination of the optimal electric field strength. 

Phrase: "Transient transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an electroporation system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Biotechnologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005574:Biotechnologies [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Experimental Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0681814:experimental research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "after"

Phrase: "determination of the optimal electric field strength."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.48: Five micrograms of steroid-responsive luciferase reporter gene (MTV-LUC) were cotransfected with 5 g pCH110 (Pharmacia LKB, Freiburg, Germany), a simian virus 40 promoter-driven -galactosidase expression vector. 

Phrase: "Five micrograms of steroid-responsive luciferase reporter gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439211:microgram [Quantitative Concept]

Phrase: "(MTV-LUC"

Phrase: ")"

Phrase: "were"

Phrase: "cotransfected with 5 g pCH110"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "(Pharmacia LKB,"

Phrase: "Freiburg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "a simian virus 40 promoter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0038975:Simian virus 40 [Virus]

Phrase: "driven -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "galactosidase expression vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.49: Electroporated cells were replated in DMEM supplemented with 10% steroid-free (charcoal-stripped) FCS and incubated immediately with various concentrations of dexamethasone. 

Phrase: "Electroporated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "replated in DMEM"

Phrase: "supplemented with 10% steroid-free"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0038317:Steroid [Steroid]
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "(charcoal-stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1321564:Strip [Medical Device]

Phrase: ")"

Phrase: "FCS"

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "immediately with various concentrations of dexamethasone."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   753   C0086045:Concentrations [Mental Process]
   753   C0205548:Immediately [Temporal Concept]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   719 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.50: Charcoal stripping of FCS was performed using Dextran T-70 (Pharmacia, Uppsala, Sweden) as described previously (23). 

Phrase: "Charcoal stripping of FCS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185047:Stripping [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Dextran T-70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011802:Dextran T 70 [Carbohydrate,Pharmacologic Substance]
   913   C0011795:Dextran 70 [Carbohydrate,Pharmacologic Substance]
   827   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "(Pharmacia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.51: After 24 h, cells were harvested, and extracts were assayed for luciferase and -galactosidase activities as a control for transfection efficiency, as previously described (23, 24, 25, 26). 

Phrase: "After 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "and"

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "assayed for luciferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "and -"

Phrase: "galactosidase activities as a control"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C1150051:galactosidase activity [Molecular Function]
   760   C0441655:Activities [Activity]
   756   C1706449:Active Control [Research Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "for transfection efficiency,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24,"

Phrase: "25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.52: Cell survival assays Neuronal cell death was estimated by three different assays: 1) microscopical examination of the cells with phase contrast microscopy to monitor for morphological changes in the absence of knowledge of the condition, 2) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay (6, 27), and 3) trypan blue exclusion staining followed by cell counting (6, 21). 

Phrase: "Cell survival assays Neuronal cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0007587:Cell Death [Cell Function]
   803   C2754100:neuron death [Cell Function]
   799   C0011065:Death [Organism Function]
   799   C1306577:Death, NOS [Finding]

Phrase: "was"

Phrase: "estimated by three different assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205449:Three [Quantitative Concept]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1705242:Different [Qualitative Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "microscopical examination of the cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1287300:Examination of cells [Laboratory Procedure]
   756   C0026018:Microscopic examination [Laboratory Procedure]

Phrase: "with phase contrast microscopy to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   861   C0444701:Phase contrast [Laboratory Procedure]
   812   C0026018:Microscopy [Laboratory Procedure]
   812   C0205390:Phase [Temporal Concept]
   812   C1979874:Contrast [Qualitative Concept]
   741 E C0205288:Microscopic [Qualitative Concept]

Phrase: "monitor for morphological changes"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0030695:monitor [Health Care Activity]
   770   C0150369:monitor [Health Care Activity]
   770   C0181904:Monitor [Medical Device]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0543482:morphological [Spatial Concept]
   770   C0596972:Monitor [Medical Device]
   770   C1521743:Monitor [Professional or Occupational Group]
   770   C1704646:Monitor [Manufactured Object]
   766   C1260954:Morphologic change [Anatomical Abnormality]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "of the condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl-tetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(6,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "trypan blue exclusion staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "followed by cell counting"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0007584:cell counting [Laboratory Procedure]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(6,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.53: For all of these assays, culture medium was switched 24 h before hormone addition to DMEM (1000 mg/liter glucose) supplemented with 10% charcoal-stripped steroid-free FCS. 

Phrase: "For all"

Phrase: "of these assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "switched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "24 h before hormone addition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "to DMEM"

Phrase: "(1000 mg/liter glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "supplemented with 10% charcoal-stripped steroid-free FCS."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0038317:Steroid [Steroid]
   744   C0332296:free [Functional Concept]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   711   C0242295:Supplement [Food]
   711   C1321564:Strip [Medical Device]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.54: Primary cultures were cultivated in FCS-free DMEM (1000 mg/liter glucose) 24 h before cell survival assessment. 

Phrase: "Primary cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0010453:Cultures [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "cultivated in FCS-free DMEM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "(1000 mg/liter glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "24 h before cell survival assessment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.55: The MTT assay was performed as described previously (6, 21). 

Phrase: "The MTT assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(6,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.56: Briefly, 10003000 HT22 cells or 10,000 primary neurons were plated in 96-well microtiter dishes with 100 l medium/well. 

Phrase: "Briefly,"

Phrase: "10003000 HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "10,000 primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "plated in 96-well microtiter dishes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1709027:Microtiter Plate [Research Device]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]
   719   C0005971:Plate [Medical Device]
   719   C0020498:DISH [Disease or Syndrome]
   719   C1139930:plate [Medical Device]
   719   C3537155:Plate [Manufactured Object]

Phrase: "with 100 l medium/well."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0009458:Medium [Intellectual Product]
   812   C0205170:Well [Qualitative Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3146287:Well [Manufactured Object]
   812   C3244283:medium [Intellectual Product]
Processing 00000000.tx.57: Hormones were added the next day. 

Phrase: "Hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "the next day."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.58: The toxins were added 24 h later. 

Phrase: "The toxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "24 h later."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.59: After 6 h, 10 l MTT (5 mg/ml stock) were added to each well, and the incubation was continued for 4 h. 

Phrase: "After 6 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "10 l MTT (5 mg/ml stock"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1710198:Stock [Idea or Concept]
   713   C3642199:10^5/mL [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "added to each well,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the incubation"

Phrase: "was"

Phrase: "continued for 4 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0549178:Continued [Idea or Concept]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.60: Finally, 100 l solubilization solution (50% dimethylformamide and 20% SDS, pH 4.8) were added. 

Phrase: "Finally,"

Phrase: "100 l solubilization solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(50% dimethylformamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012426:Dimethylformamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "20% SDS,"

Phrase: "pH 4.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "were"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.61: Adsorption readings were performed at 570 nm. 

Phrase: "Adsorption readings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0034754:Readings [Daily or Recreational Activity]
   827 E C1705179:Reading [Finding]

Phrase: "were"

Phrase: "performed at 570 nm."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.62: To assess cell lysis, trypan blue staining was performed as previously described (6, 21). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "cell lysis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "trypan blue staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(6,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.63: Briefly, cells were plated in 60-mm dishes and left untreated overnight. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in 60-mm dishes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0005971:Plate [Medical Device]
   726   C0020498:DISH [Disease or Syndrome]
   726   C1139930:plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "untreated overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.64: Then hormones were added for 24 h, followed by the addition of glutamate. 

Phrase: "Then hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "were"

Phrase: "added for 24 h,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "followed by the addition of glutamate."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1883712:Addition [Functional Concept]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.65: After an additional 24 h, trypan blue at a concentration of 0.12% was added, and the number of viable cells (trypan blue-excluding) per low magnification field was determined. 

Phrase: "After an additional 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "trypan blue at a concentration of 0.12%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1260957:Blue [Qualitative Concept]
   744   C1565627:Trypan [Organic Chemical]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the number of viable cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(trypan blue-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1260957:Blue [Qualitative Concept]
   861   C1565627:Trypan [Organic Chemical]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: ")"

Phrase: "per low magnification field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C3539073:FIELD [Spatial Concept]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.66: Because dexamethasone, corticosterone, and RU486 stock solutions (10-2 M) were prepared in ethanol, a possible ethanol effect was also assessed. 

Phrase: "Because"

Phrase: "dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "corticosterone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "RU486 stock solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "(10-2"

Phrase: "M)"

Phrase: "were"

Phrase: "prepared in ethanol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   756   C1521827:Prepare [Functional Concept]

Phrase: "a possible ethanol effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.67: Cell viability was not influenced by 0.1% ethanol in the incubation medium. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influenced by 0.1% ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001962:Ethanol [Organic Chemical]

Phrase: "in the incubation medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.68: Also, there was no interference of corticosterone, dexamethasone, or RU486 with the colorimetric MTT assay. 

Phrase: "Also,"

Phrase: "there"

Phrase: "was"

Phrase: "no interference of corticosterone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521102:Interference [Qualitative Concept]

Phrase: "dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "RU486 with the colorimetric MTT assay."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0701303:RU486 [Pharmacologic Substance,Steroid]
Processing 00000000.tx.69: All MTT and trypan blue exclusion assays were repeated three to five times in triplicate, with similar results. 

Phrase: "All MTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "and"

Phrase: "trypan blue exclusion assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three to five times in triplicate,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.70: An ANOVA with post-hoc tests was performed, and P values are presented.  

Phrase: "An ANOVA with post-hoc tests"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.71: Results Top Abstract Introduction Materials and Methods Results Discussion References  Clonal hippocampal HT22 cells express endogenous GRs Rat hippocampal neurons express functional GRs (1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Clonal hippocampal HT22 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0009013:Clone Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "endogenous GRs Rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "express"

Phrase: "functional GRs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   867 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   867 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017710:Glucocorticoid [Hormone,Steroid]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.72: By using transient transfection assays with MTV-LUC-containing GR-responsive elements, we also detected functional endogenous GRs in the clonal mouse hippocampal cell line HT22. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transient transfection assays with MTV-LUC-containing GR-responsive elements,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   739   C0040704:Transient [Population Group]
   739   C0205374:Transient [Temporal Concept]
   706   C0005507:Assay [Laboratory Procedure]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]

Phrase: "we also"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "functional endogenous GRs in the clonal mouse hippocampal cell line HT22."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   736   C0017710:Glucocorticoid [Hormone,Steroid]
   736   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C1514760:Receptor Cell [Cell]
   719 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   719 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.73: As demonstrated in Fig. 

Phrase: "As"

Phrase: "demonstrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.74: 1, HT22 cells express endogenous functional GRs that can be stimulated by increasing the concentration of dexamethasone, a synthetic glucocorticoid. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "endogenous functional GRs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   827 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   827 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0017710:Glucocorticoid [Hormone,Steroid]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "stimulated by increasing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0442808:Increasing [Functional Concept]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the concentration of dexamethasone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "a synthetic glucocorticoid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017711:Synthetic glucocorticoid [Pharmacologic Substance,Steroid]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
Processing 00000000.tx.75: Therefore, in addition to rat primary hippocampal neurons, HT22 cells provide an ideal model system to study the influence of activated endogenous GRs on oxidative cell death in a highly reproducible manner with sensitive toxicity assays. 

Phrase: "Therefore,"

Phrase: "in addition to rat primary hippocampal neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an ideal model system to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0026339:Model System [Intellectual Product,Research Device]
   861   C3161035:Model System [Intellectual Product]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the influence of activated endogenous GRs"

Phrase: "on oxidative cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "in a highly reproducible manner"

Phrase: "with sensitive toxicity assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.76: View larger version (14K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.77: Detection of endogenous GR in HT22 cells. 

Phrase: "Detection of endogenous GR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in HT22 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.78: HT22 cells were transfected with the glucocorticoid-responsive reporter plasmid MTV-LUC and incubated with increasing concentrations of dexamethasone (Dex). 

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the glucocorticoid-responsive reporter plasmid MTV-LUC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0017710:Glucocorticoid [Hormone,Steroid]
   742   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205342:Responsive [Functional Concept]
   742   C0335038:Reporter [Professional or Occupational Group]
   742   C0596883:MTV [Virus]
   742   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   742   C1705915:Reporter [Conceptual Entity]
   742   C1709908:Reporter [Group]

Phrase: "and"

Phrase: "incubated with increasing concentrations of dexamethasone (Dex)."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   753   C0086045:Concentrations [Mental Process]
   753   C0442808:Increasing [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.79: Luciferase and -galactosidase assays were performed as described in Materials and Methods. 

Phrase: "Luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and -"

Phrase: "galactosidase assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.80: Results are shown in arbitrary units of luciferase activity (relative light units, RLU) corrected for transfection efficiency by the corresponding -galactosidase activity and are presented as the average of at least five independent transfection experiments, with a variation from the mean of less than 25%.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown in arbitrary units of luciferase activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C1151115:luciferase activity [Molecular Function]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0205177:Activity [Functional Concept]
   748   C0439148:Units [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1264693:*Arbitrary [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   748   C1561536:*Activity [Idea or Concept]
   745   C0439183:Arbitrary unit [Quantitative Concept]
   714   C1547282:Show [Intellectual Product]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: "(relative light units,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "RLU"

Phrase: ")"

Phrase: "corrected for transfection efficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0205202:Corrected [Qualitative Concept]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "by the corresponding -galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "are"

Phrase: "presented as the average of"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449450:Presented [Idea or Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "at least five independent transfection experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "with a variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "from the mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 25%."
Processing 00000000.tx.81: A- and glutamate-induced oxidative cell death is specifically enhanced by glucocorticoids in HT22 cells and primary hippocampal neurons A2535, the toxic fragment of A (10), is toxic to HT22 cells, as first evaluated using phase contrast microscopy. 

Phrase: "A-"

Phrase: "and"

Phrase: "glutamate-induced oxidative cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "specifically"

Phrase: "enhanced by glucocorticoids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017710:Glucocorticoids [Hormone,Steroid]
   790   C2349975:Enhanced [Activity]

Phrase: "in HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary hippocampal neurons A2535,"

Phrase: "the toxic fragment of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "toxic to HT22 cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "as"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phase contrast microscopy."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   901   C0444701:Phase contrast [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0205390:Phase [Temporal Concept]
   827   C1979874:Contrast [Qualitative Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.82: After a 24-h incubation with 20 M A2535, dead cells were clearly visible in HT22 cell cultures (Fig. 2B); 

Phrase: "After a 24-h incubation"

Phrase: "with 20 M A2535,"

Phrase: "dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "clearly visible in HT22 cell cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205379:Visible [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.83: cellular extensions were retracted, and cell bodies appeared rounded. 

Phrase: "cellular extensions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0231448:extensions [Functional Concept]
   827 E C1880641:Extension [Conceptual Entity]

Phrase: "were"

Phrase: "retracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332523:Retracted [Finding]
  1000   C3245508:retracted [Idea or Concept]

Phrase: ","

Phrase: "and"

Phrase: "cell bodies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   966   C0599444:Cell body [Cell Component]
   966   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:bodies [Human]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "rounded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Rounded [Spatial Concept]
Processing 00000000.tx.84: To quantify these observations, the MTT assay was used (Fig. 3A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "these observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "the MTT assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.85: View larger version (66K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.86: A2535 and glutamate toxicity in mouse clonal hippocampal HT22 cells as assessed by light microscopy. 

Phrase: "A2535"

Phrase: "and"

Phrase: "glutamate toxicity in mouse clonal hippocampal HT22 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040539:toxicity [Qualitative Concept]
   744   C0600688:Toxicity [Injury or Poisoning]

Phrase: "as"

Phrase: "assessed by light microscopy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0430389:Light microscopy [Laboratory Procedure]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C1306462:Light [Functional Concept]
   770   C1516048:Assessed [Activity]
   770   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.87: HT22 cells were plated and incubated with either 20 M A2535 (B) or 1 mM glutamate (C) for 24 h. 

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "incubated with either 20 M A2535"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "1 mM glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(C) for 24 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.88: Cell cultures were viewed with phase contrast microscopy and photographed. 

Phrase: "Cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "viewed with phase contrast microscopy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   806   C0444701:Phase contrast [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1979874:Contrast [Qualitative Concept]
   726   C0449911:View [Spatial Concept]

Phrase: "and"

Phrase: "photographed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0441468:photograph [Manufactured Object]
Processing 00000000.tx.89: Degenerated cells are depicted by black arrows. 

Phrase: "Degenerated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "depicted by black arrows."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0336721:arrows [Manufactured Object]
   770   C0439541:Black [Qualitative Concept]
Processing 00000000.tx.90: A, Untreated control culture. 

Phrase: "A,"

Phrase: "Untreated control culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.91: Bar = 50 m.  

Phrase: "Bar = 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.92: View larger version (41K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.93: Effects of glucocorticoids on A2535 (A) and glutamate (B) toxicity in HT22 cells and on the toxicity of increasing concentrations of A2535 in primary hippocampal neurons (C). 

Phrase: "Effects of glucocorticoids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   824   C3179152:Glucocorticoid Effect [Physiologic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on A2535 (A)"

Phrase: "and"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(B) toxicity in HT22 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and on the toxicity of increasing concentrations of A2535"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0040539:toxicity [Qualitative Concept]
   742   C0086045:Concentrations [Mental Process]
   742   C0442808:Increasing [Functional Concept]
   742   C0600688:Toxicity [Injury or Poisoning]
   742   C1515981:And [Idea or Concept]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "in primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.94: The viability of cells with and without a 24-h preincubation with dexamethasone or corticosterone was assessed using MTT assays. 

Phrase: "The viability of cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0007620:Cell Viability [Cell Function]
   783 E C1441322:Viable cells [Cell]
   770   C0443348:viability [Qualitative Concept]

Phrase: "with"

Phrase: "and without a 24-h preincubation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "with dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MTT assays."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C2986858:MTT Assay [Research Activity]
   861   C0647210:mtt [Lipid]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.95: Data are the mean  SEM of triplicate determinations. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the mean  SEM of triplicate determinations."
Processing 00000000.tx.96: P values were as follows: A, P* and P** < 0.01; 

Phrase: "P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "A,"

Phrase: "P*"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P** < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.97: B and C, P* and P** < 0.001. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "P*"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P** < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.98: The viability of the HT22 cells was 93  2% after incubation with 10-5 M dexamethasone alone and 89  5% after incubation with 10-5 M corticosterone alone. 

Phrase: "The viability of the HT22 cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0007620:Cell Viability [Cell Function]
   753   C0443348:viability [Qualitative Concept]
   748 E C1441322:Viable cells [Cell]

Phrase: "was"

Phrase: "93  2% after incubation"

Phrase: "with 10-5 M dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   756 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   756 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   756 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "89  5% after incubation"

Phrase: "with 10-5 M corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.99: The viability of primary hippocampal neurons was also unaltered, as the cell viability was 96  5% after treatment with 10-5 M dexamethasone alone and 92  4% after treatment with 10-5 M corticosterone alone. 

Phrase: "The viability of primary hippocampal neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443348:viability [Qualitative Concept]

Phrase: "was"

Phrase: "also unaltered,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709843:Unaltered [Qualitative Concept]

Phrase: "as"

Phrase: "the cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "96  5% after treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0001758:After-Treatment [Health Care Activity]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 10-5 M dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   756 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   756 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   756 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "92  4% after treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0001758:After-Treatment [Health Care Activity]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 10-5 M corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.100: Lower glucocorticoid concentrations did not alter cell survival.  

Phrase: "Lower glucocorticoid concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.101: HT22 cells are particularly sensitive to the excitatory amino acid glutamate (13). 

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "particularly sensitive to the excitatory amino acid glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332324:Sensitive to [Functional Concept]
           Sensitive
   744   C1550474:sensitive [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.102: Glutamate-induced cell death was detected morphologically using phase contrast microscopy (Fig. 2C) or quantitatively with the MTT assay (Fig. 3B) or trypan blue exclusion staining followed by cell counting (Table 1). 

Phrase: "Glutamate-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "morphologically"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phase contrast microscopy"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   901   C0444701:Phase contrast [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0205390:Phase [Temporal Concept]
   827   C1979874:Contrast [Qualitative Concept]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "or"

Phrase: "quantitatively with the MTT assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986858:MTT Assay [Research Activity]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C0647210:mtt [Lipid]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "or"

Phrase: "trypan blue exclusion staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "followed by cell counting"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0007584:cell counting [Laboratory Procedure]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.104: Enhanced glutamate toxicity in HT22 cells after pretreatment with corticosterone and dexamethasone and block by RU486, as assessed by trypan blue exclusion staining followed by cell countings  To investigate the influence of glucocorticoids on the course of cell death induced by the oxidative stressors A and glutamate, HT22 cells and primary hippocampal neurons were treated with either different concentrations of corticosterone, the major naturally occurring glucocorticoid in rodents, or the synthetic glucocorticoid dexamethasone. 

Phrase: "Enhanced glutamate toxicity in HT22 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]

Phrase: "after pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "block by RU486,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0028778:Block [Pathologic Function]
   790   C0332206:Block [Functional Concept]
   790   C1533157:Block [Substance]
   790   C1706084:Block [Geographic Area]
   790   C2828370:Block [Quantitative Concept]
   718 E C2983591:BLOCKED [Research Activity]

Phrase: "as"

Phrase: "assessed by trypan blue exclusion staining"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0487602:Staining [Laboratory Procedure]
   753   C0680251:EXCLUSION [Functional Concept]
   753   C1260957:Blue [Qualitative Concept]
   753   C1516048:Assessed [Activity]
   753   C1565627:Trypan [Organic Chemical]
   753   C1704680:Staining [Finding]
   753   C2828389:Exclusion [Activity]

Phrase: "followed by cell countings  To"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the influence of glucocorticoids"

Phrase: "on the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by the oxidative stressors A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205263:Induced [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C0597530:stressors [Idea or Concept]

Phrase: "and"

Phrase: "glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "treated with either different concentrations of corticosterone,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]
   748   C0086045:Concentrations [Mental Process]
   748   C1522326:Treated [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "the major naturally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205164:Major [Qualitative Concept]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "glucocorticoid in rodents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017710:Glucocorticoid [Hormone,Steroid]

Phrase: "or"

Phrase: "the synthetic glucocorticoid dexamethasone."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   771 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   771 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   771 E C0740057:Decadron [Pharmacologic Substance,Steroid]
   734   C0017711:Synthetic glucocorticoid [Pharmacologic Substance,Steroid]
Processing 00000000.tx.105: A 24-h preincubation with these glucocorticoids further decreased the viability of HT22 cells after exposure to A2535 or glutamate (Fig. 3, A and B). 

Phrase: "A 24-h preincubation with these glucocorticoids further"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the viability of HT22 cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0007620:Cell Viability [Cell Function]
   762 E C1441322:Viable cells [Cell]
   760   C0443348:viability [Qualitative Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to A2535"

Phrase: "or"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.106: For A, pretreatment with 10-5 M dexamethasone followed by a toxic challenge with 1 M A2535 led to a significant increase (20%; P < 0.01) in toxicity compared to that in cells incubated with A alone. 

Phrase: "For A,"

Phrase: "pretreatment with 10-5 M dexamethasone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "followed by a toxic challenge"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0600688:toxic [Injury or Poisoning]
   760   C0798503:Challenge [Clinical Attribute]
   760   C0805586:Challenge [Health Care Activity]
   760   C1407029:Toxic [Qualitative Concept]
   760   C3274764:Challenge [Conceptual Entity]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with 1 M A2535"

Phrase: "led to a significant increase"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(20%"

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.107: Preincubation of these cells with 10-5 M corticosterone had comparable A toxicity-enhancing effects (Fig. 3A). 

Phrase: "Preincubation of these cells"

Phrase: "with 10-5 M corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "had"

Phrase: "comparable A toxicity-enhancing effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1280500:effects [Qualitative Concept]
   800   C0600688:Toxic effect [Injury or Poisoning]
   771 E C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.108: HT22 cell viability after a challenge with 1 mM glutamate was also decreased, as only 18  3% of HT22 cells survived after pretreatment with 10-5 M dexamethasone compared to 55  4% of nonhormone-treated cells. 

Phrase: "HT22 cell viability after a challenge"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007620:Cell Viability [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0443348:viability [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "with 1 mM glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "as"

Phrase: "only 18  3% of HT22 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "survived after pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   756   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "with 10-5 M dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   756 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   756 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   756 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "compared to 55  4% of nonhormone-treated cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   744   C0007634:Cells [Cell]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0450382:55 [Intellectual Product]
   744   C1522326:Treated [Functional Concept]
   744   C1707455:Compared [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.109: Again, corticosterone had a similar effect (Fig. 3B). 

Phrase: "Again,"

Phrase: "corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "had"

Phrase: "a similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.110: A significant increase in glutamate-induced cell death in HT22 cells could be detected after preincubation of the cells with lower glucocorticoid concentrations, such as 10-6 M corticosterone or dexamethasone (Tables 1 and 2). 

Phrase: "A significant increase in glutamate-induced cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in HT22 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected after preincubation of the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with lower glucocorticoid concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "such as 10-6 M corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "(Tables 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.111: To demonstrate the glutamate toxicity-enhancing effect of glucocorticoids on cell lysis rather than on cellular viability and, therefore, to extend these MTT data, trypan blue exclusion assays were performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the glutamate toxicity-enhancing effect of glucocorticoids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C3179152:Glucocorticoid Effect [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
   738   C0600688:Toxic effect [Injury or Poisoning]

Phrase: "on cell lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "rather than on cellular viability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "these MTT data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "trypan blue exclusion assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.112: As shown for HT22 cells, 10-6 M corticosterone or dexamethasone also increased the cell lysis induced by a 24-h incubation with glutamate (Table 1). 

Phrase: "As"

Phrase: "shown for HT22 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1547282:Show [Intellectual Product]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "10-6 M corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "dexamethasone also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   805 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   805 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   805 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the cell lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "induced by a 24-h incubation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0205263:Induced [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "with glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: When primary hippocampal neurons, which are equally sensitive to A (Fig. 3) (10), were preincubated with 10-5 M dexamethasone or corticosterone, cell death induced by A2535 was also significantly enhanced (Fig. 3C). 

Phrase: "When"

Phrase: "primary hippocampal neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "which"

Phrase: "are"

Phrase: "equally sensitive to A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "preincubated with 10-5 M dexamethasone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1440942:M-5 [Immunologic Factor]
   753   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "corticosterone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by A2535"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "was"

Phrase: "also significantly"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.115: Enhanced A protein and glutamate toxicity in HT22 cells after pretreatment with corticosterone and dexamethasone, as assessed by MTT assays: effects of low and high glucose culture medium  To demonstrate the specificity of this glucocorticoid effect, GRs were antagonized using the specific GR antagonist RU486. 

Phrase: "Enhanced A protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glutamate toxicity in HT22 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "after pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "as"

Phrase: "assessed by MTT assays"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C2986858:MTT Assay [Research Activity]
   770   C0647210:mtt [Lipid]
   770   C1516048:Assessed [Activity]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: ":"

Phrase: "effects of low"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "high glucose culture medium  To"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0680299:high culture [Population Group]
   840   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   804   C0009458:Medium [Intellectual Product]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C2242979:Culture [Laboratory Procedure]
   804   C3244283:medium [Intellectual Product]

Phrase: "demonstrate"

Phrase: "the specificity of this glucocorticoid effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "GRs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "antagonized"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the specific GR antagonist RU486."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0701303:RU486 [Pharmacologic Substance,Steroid]
Processing 00000000.tx.116: RU486 (10-6 M) was added together with corticosterone (10-6 M) for 24 h before the addition of 1 mM glutamate. 

Phrase: "RU486"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0701303:RU486 [Pharmacologic Substance,Steroid]

Phrase: "(10-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439187:/10^6 [Quantitative Concept]
  1000   C1881839:10^6 [Quantitative Concept]

Phrase: "M)"

Phrase: "was"

Phrase: "added together with corticosterone"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]
   770   C1524062:Added [Functional Concept]
   770   C1883357:Together [Qualitative Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "(10-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439187:/10^6 [Quantitative Concept]
  1000   C1881839:10^6 [Quantitative Concept]

Phrase: "M) for 24 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 1 mM glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   827   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.117: With trypan blue exclusion assays followed by cell counting, a significant increase in cell survival could be detected (Table 1), indicating the specificity of this glucocorticoid effect. 

Phrase: "With trypan blue exclusion assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "followed by cell counting,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0007584:cell counting [Laboratory Procedure]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "a significant increase in cell survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0007620:Cell Survival [Cell Function]
   804   C0038952:Survival [Activity]
   804   C0220921:survival [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "the specificity of this glucocorticoid effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.118: Interestingly, enhancement of A and glutamate toxicity by glucocorticoids in our cellular hippocampal systems occurred under low glucose medium conditions only. 

Phrase: "Interestingly,"

Phrase: "enhancement of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   790   C2349975:Enhancement [Activity]

Phrase: "and"

Phrase: "glutamate toxicity by glucocorticoids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "in our cellular hippocampal systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "occurred under low glucose medium"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0860801:low glucose [Finding]
   760   C0009458:Medium [Intellectual Product]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205251:low [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   760   C1705217:Medium [Substance]
   760   C1709305:Occurred [Activity]
   760   C3244283:medium [Intellectual Product]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "only."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]
Processing 00000000.tx.119: When the cells were cultivated in high glucose conditions, no further increase in A or glutamate toxicity after preincubation with corticosterone or dexamethasone was observed, as shown for HT22 cells in Table 2.  

Phrase: "When"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultivated in high glucose conditions,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0860803:high glucose [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "no further increase in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "or"

Phrase: "glutamate toxicity after preincubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "with corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "or"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "shown for HT22 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1547282:Show [Intellectual Product]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.120: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Brain cells are at particular risk of being damaged by free radicals because the brain has a high oxygen turnover, and central nervous system (CNS) neuronal membranes are rich in polyunsaturated fatty acids, which are potential targets for lipid peroxidation. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Brain cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0596208:brain cells [Cell]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0007634:Cells [Cell]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are at particular risk of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035647:Risk [Qualitative Concept]
   760   C1551058:Are [Quantitative Concept]

Phrase: "being"

Phrase: "damaged by free radicals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   770   C0302912:radicals [Chemical Viewed Structurally]
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   737   C0010957:Damage [Injury or Poisoning]
   737 E C0439807:Radical [Qualitative Concept]
   737   C1883709:Damage [Functional Concept]

Phrase: "because"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "a high oxygen turnover,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "central nervous system (CNS) neuronal membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0025255:Membranes [Tissue]
   771 E C0596901:Membrane [Cell Component]
   771 E C1706182:Membrane [Manufactured Object]
   721 E C0205287:Membranous [Qualitative Concept]
   717   C0927232:Central Nervous System [Body System]
   717   C1269563:Central nervous system [Body System]

Phrase: "are"

Phrase: "rich in polyunsaturated fatty acids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0699759:Rich [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "potential targets for lipid peroxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.121: An imbalance of the equilibrium between free radical generation and various antioxidant defense systems leading to the accumulation of free radicals is called oxidative stress (28). 

Phrase: "An imbalance of the equilibrium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1397014:Imbalance [Sign or Symptom]

Phrase: "between free radical generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "various antioxidant defense systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "leading to the accumulation of free radicals"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   778   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   748   C0302912:radicals [Chemical Viewed Structurally]
   748   C0332152:Leading [Temporal Concept]
   748   C0332296:free [Functional Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C0439807:Radical [Qualitative Concept]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.122: When cellular antioxidant defense systems are compromised, oxidative stress may occur, as demonstrated for glutamate toxicity in neuronal cell lines in vitro (12, 13). 

Phrase: "When"

Phrase: "cellular antioxidant defense systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: ","

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "as"

Phrase: "demonstrated for glutamate toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "in neuronal cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.123: Free radicals and oxidative stress-induced neuronal cell death have been implicated in various neurological disorders, such as Parkinsons disease and AD (29, 30). 

Phrase: "Free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "oxidative stress-induced neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C2754100:neuronal cell death [Cell Function]
           neuron death
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in various neurological disorders,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0027765:Neurological Disorders [Disease or Syndrome]
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0205494:Neurological [Qualitative Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C2707261:Neurological [Clinical Attribute]

Phrase: "such as Parkinsons disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.124: Recently, we demonstrated that the AD-associated A accumulating in CNS plaques of AD patients brains induces the generation of oxygen-free radicals, ultimately leading to the peroxidation of membrane lipids and cell lysis (6). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the AD-associated A accumulating in CNS plaques"

Phrase: "of AD patients brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the generation of oxygen-free radicals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "ultimately"

Phrase: "leading to the peroxidation of membrane lipids"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   778   C0025249:Membrane Lipids [Cell Component,Lipid]
   757   C0023775:Lipid Peroxidation [Molecular Function]
   748   C0023779:Lipids [Lipid]
   748   C0025255:Membrane [Tissue]
   748   C0178796:peroxidation [Phenomenon or Process]
   748   C0332152:Leading [Temporal Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1522538:Leading [Functional Concept]
   748   C1706182:Membrane [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.125: As age is the primary risk factor for AD, the investigation of age-associated physiological and pathophysiological changes that may potentially affect the vulnerability of neurons is of central importance. 

Phrase: "As age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "the primary risk factor for AD,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0679238:disease factor [Functional Concept]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "the investigation of age-associated physiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]

Phrase: "and"

Phrase: "pathophysiological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "potentially"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the vulnerability of neurons"

Phrase: "is of central importance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Central [Spatial Concept]
   770   C1879652:Central - [Laboratory Procedure]
Processing 00000000.tx.126: It has been shown repeatedly that under certain conditions glucocorticoids exacerbate different types of neurological insults (2, 3, 4). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "repeatedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205341:Repeatedly [Functional Concept]

Phrase: "that under certain conditions glucocorticoids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017710:Glucocorticoids [Hormone,Steroid]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "exacerbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "different types of neurological insults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.127: As the hippocampus is a major target for neuronal degeneration in the brains of patients with AD, and as it is richly endowed with GRs, it is also a principal target site for glucocorticoids. 

Phrase: "As the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a major target for neuronal degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "richly"

Phrase: "endowed with GRs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   799 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   799 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0017710:Glucocorticoid [Hormone,Steroid]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "a principal target site for glucocorticoids."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.128: The goal of our study was to investigate the influence of glucocorticoids on the sensitivity of hippocampal neurons to the potential oxidative stressors A and glutamate. 

Phrase: "The goal of our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018017:Goal [Intellectual Product]
   760   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the influence of glucocorticoids"

Phrase: "on the sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "of hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to the potential oxidative stressors A"

Phrase: "and"

Phrase: "glutamate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.129: In addition to rat primary hippocampal neurons, we used cells of the clonal mouse hippocampal cell line HT22. 

Phrase: "In addition to rat primary hippocampal neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cells of the clonal mouse hippocampal cell line HT22."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1513528:Mouse Cell Line [Cell]
   762   C0007600:cells line [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   726   C0009013:Clone Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.130: Here we report that the glucocorticoids corticosterone and dexamethasone enhance cell death induced by the oxidative stressors A and glutamate in HT22 cells and cell death induced by A in rat primary hippocampal neurons. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the glucocorticoids corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by the oxidative stressors A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205263:Induced [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C0597530:stressors [Idea or Concept]

Phrase: "and"

Phrase: "glutamate in HT22 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "induced by A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "in rat primary hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.131: The concentrations of glucocorticoids used are consistent with those used in a previous study, showing that 10-5-10-7 M corticosterone can increase the vulnerability of hippocampal neurons (19). 

Phrase: "The concentrations of glucocorticoids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "consistent with those"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "used in a previous study,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0205156:Previous [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C1552607:previous [Temporal Concept]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that 10-5-10-7 M corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the vulnerability of hippocampal neurons"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.132: This increased vulnerability of hippocampal neurons was quantified with the sensitive MTT assay to detect rather early mitochondrial disturbances and changes in cellular viability, and the trypan blue exclusion assay was used to describe cell lysis. 

Phrase: "This increased vulnerability of hippocampal neurons"

Phrase: "was"

Phrase: "quantified with the sensitive MTT assay to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C2986858:MTT Assay [Research Activity]
   774   C0332324:Sensitive to [Functional Concept]
           Sensitive
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0647210:mtt [Lipid]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1550474:sensitive [Idea or Concept]
   714   C1709793:Quantify [Quantitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "rather early mitochondrial disturbances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2699787:Disturbance [Qualitative Concept]

Phrase: "and"

Phrase: "changes in cellular viability,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0443348:viability [Qualitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "the trypan blue exclusion assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "describe"

Phrase: "cell lysis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]
Processing 00000000.tx.133: The MTT assay measures the reduction of MTT to a colored formazan (27). 

Phrase: "The MTT assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the reduction of MTT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "to a colored formazan"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.134: As the major site of MTT reduction is thought to be at two stages of electron transport (31), the MTT assay is a very sensitive first assay of changes in mitochondrial activity and, therefore, of cellular viability. 

Phrase: "As the major site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of MTT reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at two stages of electron transport"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0013846:Electron Transport [Molecular Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0013852:Electron [Quantitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C1306673:Stages [Qualitative Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C2987476:Be [Conceptual Entity]
   748   C3463986:Electron [Bird]
   748   C3495449:transport [Medical Device]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the MTT assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "a very sensitive first assay of changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "in mitochondrial activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "of cellular viability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443348:viability [Qualitative Concept]
Processing 00000000.tx.135: Moreover, this assay has been shown repeatedly to be a very sensitive indicator of the cell death induced by A and other amyloidogenic peptides as well as by other oxidative stressors (6, 32, 33, 34, 35). 

Phrase: "Moreover,"

Phrase: "this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "repeatedly to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205341:Repeatedly [Functional Concept]

Phrase: "be"

Phrase: "a very sensitive indicator of the cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2985750:Death Indicator [Finding]
   744   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   744   C1235732:Indicator [Bird]
   744   C1522602:Indicator [Functional Concept]

Phrase: "induced by A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "and"

Phrase: "other amyloidogenic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "as well as by other oxidative stressors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C0311404:Oxidative [Functional Concept]
   748   C0597530:stressors [Idea or Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "(6,"

Phrase: "32,"

Phrase: "33,"

Phrase: "34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.136: Cell lysis induced by A has been demonstrated previously (6, 10, 15). 

Phrase: "Cell lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "induced by A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "previously"

Phrase: "(6,"

Phrase: "10,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.137: The excitotoxin glutamate can induce the generation of several reactive oxygen species in neurons independently of the pathway (receptor-mediated or nonreceptor-mediated) of toxicity (12, 13, 14, 15). 

Phrase: "The excitotoxin glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the generation of several reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "independently of the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "(receptor-mediated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086597:mediated [Social Behavior]
   861   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "nonreceptor-mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0086597:mediated [Social Behavior]
   861   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "of toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "(12,"

Phrase: "13,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.138: The increase in sensitivity after GR activation could be prevented by the GR antagonist RU486, indicating the receptor specificity of this effect. 

Phrase: "The increase in sensitivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "after GR activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "could"

Phrase: "be"

Phrase: "prevented by the GR antagonist RU486,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0231491:Antagonist [Organ or Tissue Function]
   753   C0701303:RU486 [Pharmacologic Substance,Steroid]
   753   C1552950:[gr] [Quantitative Concept]
   719   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "indicating"

Phrase: "the receptor specificity of this effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.139: Hence, the results of the present study support and extend our initial observations (36). 

Phrase: "Hence,"

Phrase: "the results of the present study support"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0683954:results study [Finding]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our initial observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.140: In addition, the present data are consistent with those of a very recently published report showing that corticosterone can exacerbate oxidative neuronal injury (37). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with those of a very recently published report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "can"

Phrase: "exacerbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "oxidative neuronal injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.141: Taken together, this evidence clearly suggests, as also proposed for other neurotoxic insults, an important role for glucocorticoid homeostasis in degenerative processes resulting from the oxidative challenges imposed by glutamate and A. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "this evidence clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: ","

Phrase: "as"

Phrase: "also"

Phrase: "proposed for other neurotoxic insults,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]

Phrase: "an important role for glucocorticoid homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in degenerative processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "resulting from the oxidative challenges"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0311404:Oxidative [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   760   C0805586:challenges [Health Care Activity]
   726 E C0798503:Challenge [Clinical Attribute]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
   726 E C3274764:Challenge [Conceptual Entity]

Phrase: "imposed by glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.142: The hippocampus is almost always damaged in patients with AD (38, 39, 40). 

Phrase: "The hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "almost always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2003902:Always [Temporal Concept]

Phrase: "damaged in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   756   C0010957:Damage [Injury or Poisoning]
   756   C1883709:Damage [Functional Concept]

Phrase: "with AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(38,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.143: This area of the brain is important in regulation of the stress-adaptive and stress-responsive HPA system (41), and its activity is controlled mainly by corticosteroid receptors (1). 

Phrase: "This area of the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "is"

Phrase: "important in regulation of the stress-adaptive"

Phrase: "and"

Phrase: "stress-responsive HPA system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0032022:Pituitary-Adrenal System [Body System]
   827   C0683205:adrenal system [Organ or Tissue Function]
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "mainly by corticosteroid receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0034795:Receptors, Corticosteroid [Amino Acid, Peptide, or Protein,Receptor]
   770   C0001617:corticosteroid [Hormone,Pharmacologic Substance,Steroid]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C3536709:Corticosteroid [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.144: An altered response of the HPA system may lead to increased glucocorticoid levels (5). 

Phrase: "An altered response of the HPA system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "lead to increased glucocorticoid levels"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   835   C1318746:increased lead levels [Finding]
   797   C0428255:lead levels [Laboratory or Test Result]
   797   C0861064:increased lead [Finding]
   781 E C0524167:Lead level [Laboratory Procedure]
   760   C0017710:Glucocorticoid [Hormone,Steroid]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.145: Although additional mechanisms cannot be ruled out, the ability of glucocorticoids to increase the vulnerability of cells has been reported to be mediated via broad catabolic disruptions of cell biology, such as energy depletion, rather than through the activation of relatively discrete mechanisms of cell death (42, 43, 44, 45). 

Phrase: "Although"

Phrase: "additional mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "cannot"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the ability of glucocorticoids to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the vulnerability of cells"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mediated via broad catabolic disruptions of cell biology,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   744   C0005532:Biology [Biomedical Occupation or Discipline]
   744   C0007634:Cell [Cell]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0311402:catabolic [Functional Concept]
   744   C0332453:disruptions [Functional Concept]
   744   C0332464:Broad [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1516314:Catabolic [Physiologic Function]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "such as energy depletion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "rather than through the activation of relatively discrete mechanisms of cell death"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   771   C1708951:Mechanism of Cell Death [Cell Function]
   753   C0007587:Cell Death [Cell Function]
   751   C1326120:cell activation [Cell Function]
   736   C0007634:Cell [Cell]
   736   C0011065:Death [Organism Function]
   736   C0441712:Mechanisms [Functional Concept]
   736   C1269647:Cell [Cell]
   736   C1306577:Death, NOS [Finding]
   736   C1704653:Cell [Medical Device]
   736   C1879547:Activation [Activity]
   736   C1948049:Cell [Spatial Concept]
   736   C2699782:Discrete [Qualitative Concept]
   703 E C1706376:Mechanism [Manufactured Object]

Phrase: "(42,"

Phrase: "43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.146: We agree with the hypothesis that GR activation can induce an energy crisis that resembles glucocorticoid-induced cellular stress (19, 43, 44, 45), as the enhancement of glutamate and A toxicity through glucocorticoids in our cellular systems could be observed only after reducing glucose levels approximately 4-fold. 

Phrase: "We"

Phrase: "agree with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C3641827:Agree [Intellectual Product]

Phrase: "that GR activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an energy crisis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231224:Crisis [Finding]

Phrase: "that"

Phrase: "resembles"

Phrase: "glucocorticoid-induced cellular stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   812   C0038435:Stress [Finding]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "(19,"

Phrase: "43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "the enhancement of glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "and"

Phrase: "A toxicity through glucocorticoids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "in our cellular systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "after"

Phrase: "reducing glucose levels approximately 4-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332462:Fold [Spatial Concept]
   799   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.147: The use of reduced glucose concentrations in the cell survival assays is consistent with previous studies (19). 

Phrase: "The use of reduced glucose concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "in the cell survival assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0007620:Cell Survival [Cell Function]

Phrase: "is"

Phrase: "consistent with previous studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.148: Hippocampal neurons may, therefore, be left glucose deprived after activation of the GRs, rendering them more vulnerable to subsequent insults. 

Phrase: "Hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: ","

Phrase: "therefore,"

Phrase: "be"

Phrase: "left glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "deprived after activation of the GRs,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   757   C1514758:Receptor Activation [Cell Function]
   748   C0017710:Glucocorticoid [Hormone,Steroid]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C1879547:Activation [Activity]
   745 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   745 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "rendering"

Phrase: "them more vulnerable to subsequent insults."
Processing 00000000.tx.149: In addition to the increased glucocorticoid levels that may occur in patients with AD (5), it is well known that the human hippocampus loses neurons with aging (38) and that there is an age-related increase in HPA system activity (46). 

Phrase: "In addition to the increased glucocorticoid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "may"

Phrase: "occur in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "with AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that"

Phrase: "the human hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "loses"

Phrase: "neurons with aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(38"

Phrase: ")"

Phrase: "and"

Phrase: "that there"

Phrase: "is"

Phrase: "an age-related increase in HPA system activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.150: Because the primary risk factor for AD is age, any model designed for the study of neuronal cell death in AD must account for age-related physiological changes. 

Phrase: "Because"

Phrase: "the primary risk factor for AD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0679238:disease factor [Functional Concept]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "any model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "designed for the study of neuronal cell death"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C2754100:neuronal cell death [Cell Function]
           neuron death
   770   C0007587:Cell Death [Cell Function]
   750   C0035171:Study Design [Research Activity]
   750   C2983265:Study Design [Intellectual Product]
           DESIGN
   750   C2986888:Study Design [Research Activity]
   744   C0007634:Cell [Cell]
   744   C0011065:Death [Organism Function]
   744   C0521390:Neuronal [Immunologic Factor]
   744   C0557651:Study [Manufactured Object]
   744   C1269647:Cell [Cell]
   744   C1306577:Death, NOS [Finding]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2603343:Study [Research Activity]
   711   C1707689:Design [Activity]

Phrase: "in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "must"

Phrase: "account for age-related physiological changes."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0001779:Age [Organism Attribute]
   753   C0205463:Physiological [Functional Concept]
   753   C0392747:changes [Functional Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0445223:Related [Finding]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]
   719 E C0163712:Relate [Organic Chemical]
   719 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.151: These changes also include a drop in antioxidant defense system expression and activity, a reduced plasticity of hippocampal GR regulation, and, ultimately, a hypersecretion of glucocorticoids (47, 48, 49). 

Phrase: "These changes also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a drop in antioxidant defense system expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1321095:Drop [Quantitative Concept]
   748   C1705648:Drop [Activity]
   748   C2347093:Drop [Quantitative Concept]
   748   C2348338:Drop [Quantitative Concept]

Phrase: "and"

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "a reduced plasticity of hippocampal GR regulation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: ","

Phrase: "ultimately,"

Phrase: "a hypersecretion of glucocorticoids"

Phrase: "(47,"

Phrase: "48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.152: A decrease in some antioxidant enzyme activities can be directly caused by high levels of glucocorticoids in the adult rat brain, as there is a 50% decrease in glutathione peroxidase activity reported for the hippocampi of glucocorticoid-treated rats (50). 

Phrase: "A decrease in some antioxidant enzyme activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "caused by high levels of glucocorticoids"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0017710:Glucocorticoids [Hormone,Steroid]
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0015127:cause [Functional Concept]
   719 E C0456079:Level [Classification]
   719   C1524003:Cause [Conceptual Entity]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the adult rat brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "there"

Phrase: "is"

Phrase: "a 50% decrease in glutathione peroxidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "reported for the hippocampi of glucocorticoid-treated rats"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   744   C0017710:Glucocorticoid [Hormone,Steroid]
   744   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0949582:Hippocampus [Fish]
   744   C1029104:Hippocampus [Fish]
   744   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   744   C1522326:Treated [Functional Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C1292734:TREAT [Functional Concept]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.153: Glutathione peroxidase is the major H2O2-detoxifying enzyme in the brain and a decrease in its activity has been shown to be involved in glutamate toxicity in neuronal cell lines (12, 13). 

Phrase: "Glutathione peroxidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "the major H2O2-detoxifying enzyme in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "and"

Phrase: "a decrease in its activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in glutamate toxicity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600688:Toxicity [Injury or Poisoning]
   770   C1314939:Involved [Functional Concept]

Phrase: "in neuronal cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.154: Recently, we have been able to show that increased expression and activity of cellular antioxidant enzymes, such as glutathione peroxidase and catalase, are sufficient to afford resistance of neuronal cells to A and that neuronal cells stably double transfected with glutathione peroxidase and catalase are significantly less sensitive to H2O2 and A than are control transfectants (35). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "been"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that increased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activity of cellular antioxidant enzymes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1148564:antioxidant activity [Molecular Function]
   781   C0243102:enzyme activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "such as glutathione peroxidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "are"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205410:Sufficient [Qualitative Concept]

Phrase: "afford"

Phrase: "resistance of neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "to A"

Phrase: "and"

Phrase: "that neuronal cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transfected with glutathione peroxidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   770   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "are"

Phrase: "significantly less sensitive to H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "A than"

Phrase: "are"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfectants"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.155: The important role of an antioxidant defense for overall cellular protection is further strengthened by several other in vitro investigations (6, 12, 13, 15). 

Phrase: "The important role of an antioxidant defense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "for overall cellular protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1545588:Protection [Finding]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "strengthened by several"

Phrase: "other in vitro investigations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C1261322:Investigations [Health Care Activity]
   793 E C1552578:investigation [Idea or Concept]
   743 E C1517586:Investigational [Qualitative Concept]
   743 E C3245491:investigational [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "(6,"

Phrase: "12,"

Phrase: "13,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.156: All of these in vivo and in vitro data are complemented by the well documented fact that one major change in the CNS that is associated with aging is free radical-induced oxidative damage (see Ref. 49 for review). 

Phrase: "All of these in vivo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]

Phrase: "and"

Phrase: "in vitro data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "are"

Phrase: "complemented by the well documented fact"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205170:Well [Qualitative Concept]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   719   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]

Phrase: "that one major change in the CNS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   810   C2499075:Central Nervous System, Change [Therapeutic or Preventive Procedure]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "associated with aging"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001811:Ageing [Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "free radical-induced oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0010957:Damage [Injury or Poisoning]
   804   C1883709:Damage [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 49 for review"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282443:Review [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.157: Therefore, we hypothesize that oxidative stressors, such as A and glutamate, can add to accumulating oxidative stress and bring additional oxidative challenges into play, thus increasing the neurodegeneration observed in AD in age-compromised neurons that may be additionally compromised by a preexisting hypercortisolism. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that oxidative stressors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597530:stressors [Idea or Concept]

Phrase: "such as A"

Phrase: "and"

Phrase: "glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "add to accumulating oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "bring"

Phrase: "additional oxidative challenges into"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0805586:challenges [Health Care Activity]
   737 E C0798503:Challenge [Clinical Attribute]
   737 E C3274764:Challenge [Conceptual Entity]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: ","

Phrase: "thus"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "observed in AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1441672:Observed [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in age-compromised neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "additionally"

Phrase: "compromised by a preexisting hypercortisolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001622:Hypercortisolism [Disease or Syndrome]
   760   C0010481:Hypercortisolism [Disease or Syndrome]
   760   C2347662:Pre-existing [Qualitative Concept]
   726   C2945640:compromise [Finding]
Processing 00000000.tx.158: In summary, our data show that the neurotoxic challenges induced by the oxidative stressors A and glutamate, two neurotoxins that have been implicated in AD (6, 7, 8, 9, 11, 15, 16), are enhanced by pretreatment of the hippocampal neurons with glucocorticoids. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the neurotoxic challenges"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0805586:challenges [Health Care Activity]
   827 E C0798503:Challenge [Clinical Attribute]
   827 E C3274764:Challenge [Conceptual Entity]

Phrase: "induced by the oxidative stressors A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205263:Induced [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C0597530:stressors [Idea or Concept]

Phrase: "and"

Phrase: "glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "two neurotoxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027934:Neurotoxins [Hazardous or Poisonous Substance]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "11,"

Phrase: "15,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "enhanced by pretreatment of the hippocampal neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   748   C0027882:Neurons [Cell]
   748   C1550147:Pretreatment [Substance]
   748   C2349975:Enhanced [Activity]
   748   C2709094:pre treatment [Temporal Concept]
   748   C3539075:Pretreatment [Temporal Concept]
   748   C3539076:Pretreatment [Activity]

Phrase: "with glucocorticoids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]
Processing 00000000.tx.159: Our findings add to the growing body of evidence that supports the idea that physiological interactions between the brain and the HPA system play a crucial role in brain aging and possibly also in the etiology of AD and other neurodegenerative and age-related neurological diseases.  

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "add to the growing body of evidence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C1268086:Body [Anatomical Structure]
   748   C1883712:Add [Functional Concept]

Phrase: "that"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that physiological interactions between the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the HPA system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0032022:Pituitary-Adrenal System [Body System]
   861   C0683205:adrenal system [Organ or Tissue Function]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in brain aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "possibly also in the etiology of AD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002395:Alzheimers disease [Disease or Syndrome]
   767   C1314792:disease etiology [Functional Concept]
           Aetiology
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015127:aetiology [Functional Concept]
   744   C1524003:Etiology [Conceptual Entity]
   744   C2362652:Possibly [Qualitative Concept]

Phrase: "and"

Phrase: "other neurodegenerative"

Phrase: "and"

Phrase: "age-related neurological diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C0027765:neurological disease [Disease or Syndrome]
   812   C0012634:Diseases [Disease or Syndrome]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.160: Acknowledgments  We thank P. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.161: Deindl for artwork, and H.-J. 

Phrase: "Deindl for artwork,"

Phrase: "and"

Phrase: "H.-J."
Processing 00000000.tx.162: Dohrmann for technical assistance. 

Phrase: "Dohrmann for technical assistance."
Processing 00000000.tx.163: We also thank Dr. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.164: D. 

Phrase: "D."
Processing 00000000.tx.165: Schubert for the generous gift of the HT22 cells, Dr. 

Phrase: "Schubert for the generous gift of the HT22 cells,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.166: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.167: Evans for providing the pRShGR plasmid, and Dr. 

Phrase: "Evans for providing"

Phrase: "the pRShGR plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.168: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.169: Renoir for providing RU486.  

Phrase: "Renoir for providing RU486."
Processing 00000000.tx.170: Footnotes  1 Supported by a postdoctoral fellowship from INSERM. 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "Supported by a postdoctoral fellowship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0015770:Fellowship [Educational Activity]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "from INSERM."
Processing 00000000.tx.171: 2 Present address: Institute for Anatomy, Charite Hospital, Humboldt University, 10098 Berlin, Germany. 

Phrase: "2 Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Institute for Anatomy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "Charite Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Humboldt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "10098 Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005125:Berlin [Geographic Area]

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.172: Received June 19, 1996.  

Phrase: "Received June 19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1996."
Processing 00000000.tx.173: References Top Abstract Introduction Materials and Methods Results Discussion References  Reul JMHM, deKloet ER 1985 Two receptor systems for corticosterone in rat brain. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reul JMHM,"

Phrase: "deKloet ER 1985 Two receptor systems for corticosterone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0449913:System [Functional Concept]
   711   C1553451:System [Manufactured Object]
   711   C1704459:System [Medical Device]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.174: Endocrinology 117:25052511[Abstract] Johnson M, Stone D, Bush L, Hanson G, Gibb J 1989 Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. 

Phrase: "Endocrinology 117"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "25052511"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Johnson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stone D,"

Phrase: "Bush L,"

Phrase: "Hanson G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Gibb J 1989 Glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.175: J Pharmacol 161:181187 Koide T, Wieloch TW, Siesjo BK 1990 Chronic dexamethasone pretreatment aggravates ischemic neuronal necrosis. 

Phrase: "J Pharmacol 161"

Phrase: ":"

Phrase: "181187 Koide T,"

Phrase: "Wieloch TW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039260:TW [Geographic Area]
   861   C0332293:TW [Therapeutic or Preventive Procedure]

Phrase: "Siesjo BK 1990 Chronic dexamethasone pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1550147:Pretreatment [Substance]
   799   C2709094:pre treatment [Temporal Concept]
   799   C3539075:Pretreatment [Temporal Concept]
   799   C3539076:Pretreatment [Activity]

Phrase: "aggravates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:aggravate [Finding]

Phrase: "ischemic neuronal necrosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0027543:Ischaemic necrosis [Pathologic Function]
   913   C3538978:Ischemic Necrosis [Pathologic Function]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C1334928:Necrosis [Finding]
Processing 00000000.tx.176: J Cereb Blood Flow Metab 6:395404 Sapolsky RM, Pulsinelli WA 1985 Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. 

Phrase: "J Cereb Blood Flow Metab 6"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   827   C0232338:Blood flow [Organism Function]
   799   C0005767:Blood [Tissue]
   799   C0005768:blood [Body Substance]
   799   C0229664:Blood [Body Substance]
   799   C0806140:Flow [Natural Phenomenon or Process]
   727 E C0333275:Bloody [Qualitative Concept]
   716 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   716 E C0392895:Bloods [Population Group]
   716 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   716 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: ":"

Phrase: "395404 Sapolsky RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2951520:RM [Body Location or Region]

Phrase: "Pulsinelli WA 1985 Glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "potentiate"

Phrase: "ischemic injury to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]

Phrase: ":"

Phrase: "therapeutic implications."
Processing 00000000.tx.177: Science 229:13971400[Medline] Hatzinger M, ZBrun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E, Heuser IJ 1995 Hypothalamic-pituitary-adrenal system function in patients with Alzheimers disease. 

Phrase: "Science 229"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "13971400"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hatzinger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "ZBrun A,"

Phrase: "Hemmeter U,"

Phrase: "Seifritz E,"

Phrase: "Baumann F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Holsboer-Trachsler E,"

Phrase: "Heuser IJ 1995 Hypothalamic-pituitary-adrenal system function in patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
   722   C1180473:Functional system [Body System]

Phrase: "with Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.178: Neurobiol Aging 16:205209[CrossRef][Medline] Behl C, Davis JB, Lesley R, Schubert D 1994 Hydrogen peroxide mediates amyloid  protein toxicity. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "16"

Phrase: ":"

Phrase: "205209"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Behl C,"

Phrase: "Davis JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Lesley R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Schubert D 1994 Hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0020275:Hydrogen [Element, Ion, or Isotope]
   804   C0031180:Peroxide [Inorganic Chemical]
   804   C0523702:HYDROGEN [Laboratory Procedure]
   804   C0885426:hydrogen [Inorganic Chemical]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "amyloid  protein toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.179: Cell 77:817827[Medline] Glenner GG 1988 Alzheimers disease: its proteins and genes. 

Phrase: "Cell 77"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "817827"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Glenner GG 1988 Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   840   C0002395:Alzheimers disease [Disease or Syndrome]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "its proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.180: Cell 52:307308[Medline] Koh JY, Yang LL, Cotman CW 1990 -Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. 

Phrase: "Cell 52"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "307308"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koh JY,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "LL,"

Phrase: "Cotman CW 1990 -Amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the vulnerability of cultured cortical neurons"

Phrase: "to excitotoxic damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.181: Brain Res 533:315320[CrossRef][Medline] Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel R 1992 -Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. 

Phrase: "Brain Res 533"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "315320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattson MP,"

Phrase: "Cheng B,"

Phrase: "Davis D,"

Phrase: "Bryant K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lieberburg I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rydel R 1992 -Amyloid peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0658411:R peptide [Amino Acid, Peptide, or Protein]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "destabilize"

Phrase: "calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "render"

Phrase: "human cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "vulnerable to excitotoxicity."
Processing 00000000.tx.182: J Neurosci 12:376389[Abstract] Yankner BA, Duffy LK, Kirschner DA 1990 Neurotrophic and neurotoxic effects of amyloid  protein: reversal by tachykinin neuropeptides. 

Phrase: "J Neurosci 12"

Phrase: ":"

Phrase: "376389"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yankner BA,"

Phrase: "Duffy LK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038088:LK [Geographic Area]
   861   C2681928:LK [Gene or Genome]

Phrase: "Kirschner DA 1990 Neurotrophic"

Phrase: "and"

Phrase: "neurotoxic effects of amyloid  protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0235032:Neurotoxic effect [Injury or Poisoning]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "reversal by tachykinin neuropeptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443290:Reversal [Functional Concept]
Processing 00000000.tx.183: Science 25:279282 Choi DW 1992 Excitotoxic cell death. 

Phrase: "Science 25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "279282 Choi DW 1992 Excitotoxic cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0007587:Cell Death [Cell Function]
   795   C0007634:Cell [Cell]
   795   C0011065:Death [Organism Function]
   795   C1269647:Cell [Cell]
   795   C1306577:Death, NOS [Finding]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.184: J Neurobiol 23:12611276[Medline] Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT 1989 Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. 

Phrase: "J Neurobiol 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "12611276"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Murphy TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Miyamoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sastre A,"

Phrase: "Schnaar RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Coyle JT 1989 Glutamate toxicity in a neuronal cell line"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0040539:toxicity [Qualitative Concept]
   739   C0600688:Toxicity [Injury or Poisoning]

Phrase: "involves"

Phrase: "inhibition of cystine transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C2259163:inhibition of transport [Cell Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "leading to oxidative stress."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.185: Neuron 2:15471558[Medline] Davis JB, Maher P 1994 Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. 

Phrase: "Neuron 2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "15471558"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Maher P 1994 Protein kinase C activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   877   C3546691:protein kinase C activation [Molecular Function]
   852   C1819041:protein kinase activation [Cell Function]
   845   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glutamate-induced cytotoxicity in a neuronal cell line."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   731   C0022686:Cytotoxic cell [Cell]
Processing 00000000.tx.186: Brain Res 652:169173[CrossRef][Medline] Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J 1993 NMDA-dependent super-oxide production and neurotoxicity. 

Phrase: "Brain Res 652"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "169173"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lafon-Cazal M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Pietri S,"

Phrase: "Culcasi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bockaert J 1993 NMDA-dependent super-oxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.187: Nature 364:535537[CrossRef][Medline] Mattson MP, Lovell MA, Furukawa K, Markesbery WR 1995 Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activites in hippocampal neurons. 

Phrase: "Nature 364"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "535537"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattson MP,"

Phrase: "Lovell MA,"

Phrase: "Furukawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Markesbery WR 1995 Neurotrophic factors"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0027754:Neurotrophic Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806 E C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806 E C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   806 E C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "glutamate-induced accumulation of peroxides,"

Phrase: "elevation of intracellular Ca2+ concentration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "and"

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "increase antioxidant enzyme activites in hippocampal neurons."
Processing 00000000.tx.188: J Neurochem 65:17401751[Medline] Choi DW 1988 Glutamate neurotoxicity and diseases of the nervous system. 

Phrase: "J Neurochem 65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "17401751"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Choi DW 1988 Glutamate neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "diseases of the nervous system."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0027765:diseases of the nervous system [Disease or Syndrome]
           Disease of nervous system
           Nervous System Diseases
           Nerve Diseases
   760   C0012634:Diseases [Disease or Syndrome]
   745   C0442893:Systemic disease [Disease or Syndrome]
Processing 00000000.tx.189: Neuron 1:623634[Medline] Paul SM, Purdy RH 1992 Neuroactive steroids. 

Phrase: "Neuron 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "623634"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paul SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Purdy RH 1992 Neuroactive steroids."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0815278:neuroactive steroids [Neuroreactive Substance or Biogenic Amine,Steroid]
   804   C0038317:Steroids [Steroid]
Processing 00000000.tx.190: FASEB J 6:23112322[Abstract/Free FullText] McEwen BS 1994 Steroid hormone actions on the brain: when is the genome involved? 

Phrase: "FASEB J 6"

Phrase: ":"

Phrase: "23112322"

Phrase: "[Abstract/Free FullText"

Phrase: "] McEwen BS 1994 Steroid hormone actions on the brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0441472:actions [Functional Concept]
   708 E C3266814:Action [Activity]

Phrase: ":"

Phrase: "when"

Phrase: "is"

Phrase: "the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "involved?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.191: Horm Behav 28:396405[CrossRef][Medline] Sapolsky RM, Packan DR, Vale WW 1988 Glucocorticoid toxicity in the hippocampus: in vitro demonstration. 

Phrase: "Horm Behav 28"

Phrase: ":"

Phrase: "396405"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sapolsky RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Packan DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Vale WW 1988 Glucocorticoid toxicity in the hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0040539:toxicity [Qualitative Concept]
   744   C0600688:Toxicity [Injury or Poisoning]

Phrase: ":"

Phrase: "in vitro demonstration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.192: Brain Res 453:369371 Landfield PW 1994 The role of glucocorticoids in brain aging and Alzheimers disease: an integrative physiological hypothesis. 

Phrase: "Brain Res 453"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "369371 Landfield PW 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242397:PW [Geographic Area]

Phrase: "The role of glucocorticoids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in brain aging"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an integrative physiological hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.193: Exp Gerontol 29:311[CrossRef][Medline] Behl C, Widmann M, Trapp T, Holsboer F 1995 17 Estradiol protects neurons from oxidative stress-induced cell death in vitro. 

Phrase: "Exp Gerontol 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "311"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Behl C,"

Phrase: "Widmann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Trapp T,"

Phrase: "Holsboer F 1995 17 Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "protects"

Phrase: "neurons from oxidative stress-induced cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C2754100:neuron cell death [Cell Function]
           neuron death
   748   C0027882:Neurons [Cell]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.194: Biochem Biophys Res Commun 216:473482[CrossRef][Medline] Morimoto BH, Koshland DE 1990 Induction and expression of long-term and short-term neurosecretory potentiation in a neural cell line. 

Phrase: "Biochem Biophys Res Commun 216"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "473482"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Morimoto BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Koshland DE 1990 Induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "expression of long-term"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "short-term neurosecretory potentiation in a neural cell line."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0279023:Potentiation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.195: Neuron 5:875880[Medline] Damm K 1994 Gene transfection studies using recombinant steroid receptors. 

Phrase: "Neuron 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "875880"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Damm K 1994 Gene transfection studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   839   C1273305:Gene studies [Laboratory Procedure]
   799   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   799   C0947630:studies [Laboratory Procedure]
   766 E C0557651:Study [Manufactured Object]
   766 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant steroid receptors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034840:Receptors, Steroid [Amino Acid, Peptide, or Protein,Receptor]
   827   C0038317:Steroid [Steroid]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.196: In: de Kloet ER, Sutanto W (eds.) 

Phrase: "In"

Phrase: ":"

Phrase: "de Kloet ER,"

Phrase: "Sutanto W (eds."

Phrase: ")"
Processing 00000000.tx.197: Methods in Neurosciences: Neurobiology of Steroids. 

Phrase: "Methods in Neurosciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "Neurobiology of Steroids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0027817:Neurobiology [Biomedical Occupation or Discipline]
Processing 00000000.tx.198: Academic Press, San Diego, pp 265276 Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. 

Phrase: "Academic Press,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "pp 265276 Arriza JL,"

Phrase: "Weinberger C,"

Phrase: "Cerelli G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Glaser TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Handelin BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Housman DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0525049:Human Cloning [Research Activity]
   739   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional kinship with the glucocorticoid receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0870772:kinship [Idea or Concept]
Processing 00000000.tx.199: Science 237:268275[Medline] de Wet JR, Wood KV, DeLuca M, Helsinki DR, Subramani S 1987 Firefly luciferase gene: structure and expression in mammalian cells. 

Phrase: "Science 237"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "268275"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "de Wet"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C0205381:Wet [Qualitative Concept]
   861   C3541240:DE [Idea or Concept]

Phrase: "JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Wood KV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556639:kV [Quantitative Concept]

Phrase: "DeLuca M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Helsinki DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Subramani S 1987 Firefly luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1334435:Luciferase Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "expression in mammalian cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.200: Mol Cell Biol 7:725737[Medline] Herbomel P, Bourachot B, Yaniv M 1984 Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. 

Phrase: "Mol Cell Biol 7"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "725737"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Herbomel P,"

Phrase: "Bourachot B,"

Phrase: "Yaniv M 1984 Two distinct enhancers with different cell specificities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "coexist in the regulatory region of polyoma."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017446:Region [Geographic Area]
   748   C0032556:Polyoma [Virus]
   748   C0205147:Region [Spatial Concept]
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]
Processing 00000000.tx.201: Cell 39:653662[Medline] Hansen MB, Nielsen SE, Berg K 1989 Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing. 

Phrase: "Cell 39"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "653662"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hansen MB,"

Phrase: "Nielsen SE,"

Phrase: "Berg K 1989 Re-examination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2986904:RE [Idea or Concept]

Phrase: "and"

Phrase: "further development of a precise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "rapid dye method for measuring cell growth/cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0872257:rapid method [Diagnostic Procedure]
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]

Phrase: "killing."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.202: J Immunol Methods 119:203210[CrossRef][Medline] Halliwell B, Gutteridge JMC 1989 Free Radicals in Biology and Medicine. 

Phrase: "J Immunol Methods 119"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "203210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Halliwell B,"

Phrase: "Gutteridge JMC 1989 Free Radicals in Biology"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   748   C0302912:radicals [Chemical Viewed Structurally]
   748   C0332296:free [Functional Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   714 E C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "Medicine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]
Processing 00000000.tx.203: Oxford University Press, Oxford, pp 188266 Olanow CW 1993 A radical hypothesis for neurodegeneration. 

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford,"

Phrase: "pp 188266 Olanow CW 1993 A radical hypothesis for neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.204: Trends Neurosci 16:439444[CrossRef][Medline] Coyle JT, Puttfarcken P 1993 Oxidative stress, glutamate, and neurodegenerative disorders. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 16"

Phrase: ":"

Phrase: "439444"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Coyle JT,"

Phrase: "Puttfarcken P 1993 Oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   804   C0038435:Stress [Finding]
   804   C0311404:Oxidative [Functional Concept]
   733 E C0231297:Stressful [Functional Concept]

Phrase: "glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.205: Science 262:689695[Medline] Slater TF, Sawyer B, Strauli U 1963 Studies of succinate reductase systems. 

Phrase: "Science 262"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "689695"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Slater TF,"

Phrase: "Sawyer B,"

Phrase: "Strauli U 1963 Studies of succinate reductase systems."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]
Processing 00000000.tx.206: III. 

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.207: Points of coupling of four different tetrazolium salts. 

Phrase: "Points of coupling of four different tetrazolium salts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1552961:Point [Quantitative Concept]
   711   C2347617:point [Quantitative Concept]
Processing 00000000.tx.208: Biochim Biophys Acta 77:383393[CrossRef] Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H 1995 Amyloid peptides are toxic via a common oxidative mechanism. 

Phrase: "Biochim Biophys Acta 77"

Phrase: ":"

Phrase: "383393"

Phrase: "[CrossRef"

Phrase: "] Schubert D,"

Phrase: "Behl C,"

Phrase: "Lesley R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brack A,"

Phrase: "Dargusch R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sagara Y,"

Phrase: "Kimura H 1995 Amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "toxic via a common oxidative mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]
Processing 00000000.tx.209: Proc Natl Acad Sci USA 92:19891993[Abstract] Shearman MS, Hawtin SR, Tailor VJ 1995 The intracellular component of cellular 3-(4,5,dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by -amyloid peptides. 

Phrase: "Proc Natl Acad Sci USA 92"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "19891993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shearman MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Hawtin SR,"

Phrase: "Tailor VJ 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0402883:Tailor [Professional or Occupational Group]

Phrase: "The intracellular component of cellular 3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1166607:cellular component [Cell Component]
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "dimethyl-thiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyltetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "specifically"

Phrase: "inhibited by -amyloid peptides."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.210: J Neurochem 65:218227[Medline] Sortino MA, Canonico PL 1996 Neuroprotective effect of insulin-like growth factor I in immortalized hypothalamic cells. 

Phrase: "J Neurochem 65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "218227"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sortino MA,"

Phrase: "Canonico PL 1996 Neuroprotective effect of insulin-like growth factor I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0815279:Neuroprotective Effect [Functional Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "in immortalized hypothalamic cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0178708:immortalized cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.211: Endocrinology 137:14181422[Abstract] Sagara Y, Dargusch R, Klier FG, Schubert D, Behl C 1996 Increased antioxidant enzyme activity in amyloid  protein-resistant cells. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "14181422"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sagara Y,"

Phrase: "Dargusch R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Klier FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Schubert D,"

Phrase: "Behl C 1996 Increased antioxidant enzyme activity in amyloid  protein-resistant cells."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C1325278:amyloid protein activity [Molecular Function]
   766   C3642159:Protein C Activity [Laboratory Procedure]
   753   C0243102:enzyme activity [Molecular Function]
   751   C0474395:increased activity [Finding]
   751   C1148564:antioxidant activity [Molecular Function]
   751   C1537044:protein activity [Molecular Function]
   736   C0014442:Enzyme [Enzyme,Organic Chemical]
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.212: J Neurosci 16:497505[Abstract] Behl C, Trapp T, Skutella T, Holsboer F 1995 Amyloid  protein toxicity and activated glucocorticoid receptors in hippocampal neurons. 

Phrase: "J Neurosci 16"

Phrase: ":"

Phrase: "497505"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Behl C,"

Phrase: "Trapp T,"

Phrase: "Skutella T,"

Phrase: "Holsboer F 1995 Amyloid  protein toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   799   C0040539:toxicity [Qualitative Concept]
   799   C0600688:Toxicity [Injury or Poisoning]
   727 E C1407029:Toxic [Qualitative Concept]
   706 E C0032346:Poison [Hazardous or Poisonous Substance]
   706 E C1548769:Poison [Intellectual Product]
   706 E C1550590:poison [Idea or Concept]

Phrase: "and"

Phrase: "activated glucocorticoid receptors in hippocampal neurons."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   756 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   756 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0017710:Glucocorticoid [Hormone,Steroid]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   725   C2325760:Neuronal receptor [Cell Component]
Processing 00000000.tx.213: Soc Neurosci Abstr 21:1010 Goodman Y, Bruce AJ, Cheng B, Mattson MP 1996 Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid -peptide toxicity in hippocampal neurons. 

Phrase: "Soc Neurosci Abstr 21"

Phrase: ":"

Phrase: "1010 Goodman Y,"

Phrase: "Bruce AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Cheng B,"

Phrase: "Mattson MP 1996 Estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   779 E C2936882:Estrogen [Pharmacologic Substance]
   729 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "and"

Phrase: "corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "excitotoxicity,"

Phrase: "oxidative injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "amyloid -peptide toxicity in hippocampal neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.214: J Neurochem 66:18361844[Medline] Ball MJ 1977 Neuronal loss, neurofibrillary tangles, and granulovacuolar degeneration in the hippocampus with aging and dementia. 

Phrase: "J Neurochem 66"

Phrase: ":"

Phrase: "18361844"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ball MJ 1977 Neuronal loss,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C1850496:Neuronal loss [Finding]
   804 E C0598940:neuron loss [Finding]
   804   C1517945:Loss [Quantitative Concept]

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "granulovacuolar degeneration in the hippocampus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0333454:Granulovacuolar degeneration [Pathologic Function]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.215: Acta Neuropathol 37:111118[Medline] Ball MJ 1978 Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. 

Phrase: "Acta Neuropathol 37"

Phrase: ":"

Phrase: "111118"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ball MJ 1978 Topographic distribution of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "granulovacuolar degeneration in hippocampal cortex of aging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0333454:Granulovacuolar degeneration [Pathologic Function]
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "demented patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.216: A quantitative study. 

Phrase: "A quantitative study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.217: Acta Neuropathol 42:7380[Medline] Coleman PD, Flood DG 1987 Neuron numbers and dendritic extent in normal aging and Alzheimers disease. 

Phrase: "Acta Neuropathol 42"

Phrase: ":"

Phrase: "7380"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Coleman PD,"

Phrase: "Flood DG 1987 Neuron numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0237753:*Number [Quantitative Concept]
   804   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "dendritic extent in normal aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.218: Neurobiol Aging 8:521545[CrossRef][Medline] Sapolsky RM, Plotsky P 1991 Hypercorticolism and its possible neural bases. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "8"

Phrase: ":"

Phrase: "521545"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sapolsky RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Plotsky P 1991 Hypercorticolism"

Phrase: "and"

Phrase: "its possible neural bases."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   827   C0178499:bases [Chemical Viewed Functionally]
   827   C1626935:Bases [Quantitative Concept]
   793 E C0002055:base [Inorganic Chemical]
   793 E C1527178:Basis [Functional Concept]
   793 E C1874451:Basis [Pharmacologic Substance]
   793 E C1880279:Base [Biomedical or Dental Material]
   743 E C0205112:Basal [Spatial Concept]
   734 E C0016617:Foundation [Organization]
Processing 00000000.tx.219: Biol Psychiatry 27:937952[CrossRef] Sapolsky RM 1990 Glucocorticoids, hippocampal damage and the glutamatergic synapse. 

Phrase: "Biol Psychiatry 27"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]

Phrase: ":"

Phrase: "937952"

Phrase: "[CrossRef"

Phrase: "] Sapolsky RM 1990 Glucocorticoids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "hippocampal damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "the glutamatergic synapse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039062:Synapse [Body Space or Junction]
Processing 00000000.tx.220: Prog Brain Res 86:1323[Medline] Lawrence MS, Sapolsky RM 1994 Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. 

Phrase: "Prog Brain Res 86"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "1323"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lawrence MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Sapolsky RM 1994 Glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "ATP loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "metabolic insults in cultured hippocampal neurons."
Processing 00000000.tx.221: Brain Res 646:303306[CrossRef][Medline] Masters JN, Finch CE, Sapolsky RM 1989 Glucocorticoid endangerment of hippocampal neurons does not involve deoxyribonucleic acid cleavage. 

Phrase: "Brain Res 646"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "303306"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Masters JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Finch CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Sapolsky RM 1989 Glucocorticoid endangerment of hippocampal neurons"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "deoxyribonucleic acid cleavage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0012854:Deoxyribonucleic Acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.222: Endocrinology 124:30833088[Abstract] Horner HC, Packan DR, Sapolsky RM 1990 Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. 

Phrase: "Endocrinology 124"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "30833088"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Horner HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Packan DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Sapolsky RM 1990 Glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glucose transport in cultured hippocampal neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0178666:glucose transport [Cell Function]
   767   C0178766:neuron transport [Cell Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]
Processing 00000000.tx.223: Neuroendocrinology 52:5764[Medline] Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers C-H, Dettling M, Holsboer F 1994 Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. 

Phrase: "Neuroendocrinology 52"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027827:Neuroendocrinology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "5764"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heuser IJ,"

Phrase: "Gotthardt U,"

Phrase: "Schweiger U,"

Phrase: "Schmider J,"

Phrase: "Lammers C-H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Dettling M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Holsboer F 1994 Age-associated changes of pituitary-adrenocortical hormone regulation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   718   C1134488:hormonal changes [Finding]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: ":"

Phrase: "importance of gender."
Processing 00000000.tx.224: Neurobiol Aging 15:227231[CrossRef][Medline] Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathe AA, Johns CA, Horvath TB 1986 Cortisol and Alzheimers disease. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "15"

Phrase: ":"

Phrase: "227231"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davis KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Davis BM,"

Phrase: "Greenwald BS,"

Phrase: "Mohs RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Mathe AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Johns CA,"

Phrase: "Horvath TB 1986 Cortisol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020268:Cortisol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.225: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.226: Basal studies. 

Phrase: "Basal studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.227: Am J Psychiatry 143:300305[Abstract] Seckl JR, Olsson T 1995 Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect? 

Phrase: "Am"

Phrase: "J Psychiatry 143"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]

Phrase: ":"

Phrase: "300305"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Seckl JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Olsson T 1995 Glucocorticoid hypersecretion"

Phrase: "and"

Phrase: "the age-impaired hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   827   C0949582:Hippocampus [Fish]
   827   C1029104:Hippocampus [Fish]
   827   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "or"

Phrase: "effect?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.228: J Endocrinol 145:201211[Medline] Ames BN, Shigenaga MK, Hagen TM 1993 Oxidants, antioxidants, and the degenerative diseases of aging. 

Phrase: "J Endocrinol 145"

Phrase: ":"

Phrase: "201211"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ames BN,"

Phrase: "Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Hagen TM 1993 Oxidants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0085403:Oxidants [Chemical Viewed Functionally]

Phrase: "antioxidants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "and"

Phrase: "the degenerative diseases of aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C1285162:Degenerative Disease [Disease or Syndrome]
   760   C0011164:Degenerative [Pathologic Function]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C1880269:Degenerative [Functional Concept]
Processing 00000000.tx.229: Proc Natl Acad Sci USA 90:79157922[Abstract/Free FullText] McIntosh LJ, Hong KE, Sapolsky RM 1995 High glucocorticoid levels decrease some antioxidant enzyme activities in the adult rat brain. 

Phrase: "Proc Natl Acad Sci USA 90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439083:>90 [Quantitative Concept]
   799   C0439087:<90 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "79157922"

Phrase: "[Abstract/Free FullText"

Phrase: "] McIntosh LJ,"

Phrase: "Hong KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Sapolsky RM 1995 High glucocorticoid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "some antioxidant enzyme activities in the adult rat brain."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   745   C0443158:Brain activity [Physiologic Function]
   745   C1148564:antioxidant activity [Molecular Function]
   745   C3176850:Adult activity [Clinical Attribute]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0441655:Activities [Activity]
   731   C0243102:enzyme activity [Molecular Function]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.230: Soc Neurosci Abstr 21:2129

Phrase: "Soc Neurosci Abstr 21"

Phrase: ":"

Phrase: "2129"

